Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.

Nagumo Y, Onozawa M, Kojima T, Terada N, Shiota M, Mitsuzuka K, Yasumoto H, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Saito T, Yokomizo A, Kohei N, Tabata KI, Takahashi A, Sugimoto M, Kitamura H, Kamoto T, Nishiyama H, Japanese Urological Oncology Group (JUOG)

Open source

DOI: 10.1111/iju.14793
Published: 2022 May
Container: International journal of urology : official journal of the Japanese Urological Association
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/iju.14793,
  title = {Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.},
  author = {Nagumo Y and Onozawa M and Kojima T and Terada N and Shiota M and Mitsuzuka K and Yasumoto H and Matsumoto H and Enokida H and Sugiyama T and Kuroiwa K and Saito T and Yokomizo A and Kohei N and Tabata KI and Takahashi A and Sugimoto M and Kitamura H and Kamoto T and Nishiyama H and Japanese Urological Oncology Group (JUOG)},
  year = {2022},
  journal = {International journal of urology : official journal of the Japanese Urological Association},
  doi = {10.1111/iju.14793},
  url = {https://doi.org/10.1111/iju.14793}
}

RIS

TY  - JOUR
TI  - Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.
AU  - Nagumo Y
AU  - Onozawa M
AU  - Kojima T
AU  - Terada N
AU  - Shiota M
AU  - Mitsuzuka K
AU  - Yasumoto H
AU  - Matsumoto H
AU  - Enokida H
AU  - Sugiyama T
AU  - Kuroiwa K
AU  - Saito T
AU  - Yokomizo A
AU  - Kohei N
AU  - Tabata KI
AU  - Takahashi A
AU  - Sugimoto M
AU  - Kitamura H
AU  - Kamoto T
AU  - Nishiyama H
AU  - Japanese Urological Oncology Group (JUOG)
PY  - 2022
JO  - International journal of urology : official journal of the Japanese Urological Association
DO  - 10.1111/iju.14793
UR  - https://doi.org/10.1111/iju.14793
ER  -

APA

Y, N., M, O., T, K., N, T., M, S., K, M., H, Y., H, M., H, E., T, S., K, K., T, S., A, Y., N, K., KI, T., A, T., M, S., H, K., T, K., H, N., & (JUOG), J. U. O. G. (2022). Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.. International journal of urology : official journal of the Japanese Urological Association. https://doi.org/10.1111/iju.14793

Source records

pubmed · retrieved 2026-09-26T17:34:17.908Z